MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,298 | -9.9% | 17,285 | -7.8% | 0.00% | – |
| Q2 2023 | $24,745 | -61.6% | 18,746 | -79.4% | 0.00% | – |
| Q1 2023 | $64,394 | -55.5% | 91,093 | -52.8% | 0.00% | – |
| Q4 2022 | $144,722 | -3.5% | 192,962 | +11.0% | 0.00% | – |
| Q3 2022 | $150,000 | +500.0% | 173,786 | +689.1% | 0.00% | – |
| Q2 2022 | $25,000 | -84.3% | 22,024 | -53.4% | 0.00% | – |
| Q1 2021 | $159,000 | +93.9% | 47,219 | +105.0% | 0.00% | – |
| Q4 2020 | $82,000 | – | 23,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
| Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
| Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
| Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
| Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
| DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
| Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
| Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |